- Researcher at the Center for Biomedical Law, Faculty of Law, University of Coimbra
- Lawyer (working in the health sector)
- Member of the Ethics Committee of the Regional Health Administration – Centro
- Lecturer in several postgraduate, master’s and doctoral courses in health
- Member of the Editorial Board of Lex Medicinae – Portuguese Journal of Health Law
- Researcher (others) at the Legal Institute of the Faculty of Law of the University of Coimbra
- External expertise in international health projects financed by the European Commission.
- Author and co-author of several articles (in national and international publications) on health law
Scientific area: On Our Agenda
27 of november, from 09h00 until 09h30
The discussion around telemedicine has been in place in Europe for over a decade. However, reality has shown that telemedicine has only gained relevance in recent years with the flourishing of health apps, with the increase in the so-called mHealth. Telemedicine, which in its most traditional sense, was challenged in 2020 with the pandemic and its use has increased exponentially.
Despite the advantages of its use, many continue, however, to highlight its inconveniences and to put obstacles to the use of this tool that they see only as a resource and complementary instrument.
The topic continues to be challenging both for health and for the law, raising very interesting questions about the type of telemedicine, professional secrecy, personal health data and other personal data, and cross-border healthcare, etc.